Predictive biomarkers for cardiometabolic risk in postmenopausal women: insights into visfatin, adropin, and adiponectin
BackgroundVisfatin, adropin, and adiponectin are involved in many changes associated with obesity and metabolic disorders, and may be related to metabolic syndrome and cardiovascular disease. The selection of visfatin, adropin, and adiponectin as biomarkers is based on their significant roles in met...
Saved in:
| Main Authors: | Anna Maria Cybulska, Daria Schneider-Matyka, Ireneusz Walaszek, Mariusz Panczyk, Dorota Ćwiek, Anna Lubkowska, Elżbieta Grochans, Kamila Rachubińska, Katarzyna Malewicz, Mariusz Chabowski |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1527567/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adropin ameliorates reproductive dysfunctions in letrozole-induced PCOS mouse
by: Shweta Maurya, et al.
Published: (2025-03-01) -
Adropin: a key player in immune cell homeostasis and regulation of inflammation in several diseases
by: Junmin Wang, et al.
Published: (2025-01-01) -
Evaluation of Salivary Chemerin and Visfatin in Relation to Periodontitis and Obesity
by: Farah Razak Abood, et al.
Published: (2025-04-01) -
Adropin and Preptin Levels in β-Thalassemia Major Complications in Babylon Province
by: Zinah Abbass Ali, et al.
Published: (2024-12-01) -
Adropin exerts neuroprotection in an experimental rat model of Parkinson’s disease
by: Ayse Ozkan, et al.
Published: (2025-06-01)